Ligand Pharma (LGND) PT Raised to $335 at Benchmark as XOMA Royalty Cash Acquisition Completed
(Updated - July 16, 2026 9:56 AM EDT)
Benchmark analyst Robert Wasserman raised the price target on Ligand Pharma ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Benchmark analyst Robert Wasserman raised the price target on Ligand Pharma ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
